Table 3. Relationship between clinical parameters, MEX3A mRNA expression and overall survival in liver cancer patients.

	Univariate analysis			Multivariate analysis
Parameters	Hazard ratio	95%CI (lower∼upper)	P value	Hazard ratio	95%CI (lower–upper)	P value
Age	1.00	0.69–1.45	0.997
Gender	0.80	0.56–1.14	0.220
Histological type	0.99	0.27–3.66	0.986
Histologic grade	1.04	0.84–1.3	0.698
Stage	1.38	1.15–1.66	0.001	0.86	0.69–1.07	0.163
T classification	1.66	1.39–1.99	0.000	1.88	1.48–2.38	0.000
N classification	0.73	0.51–1.05	0.086
M classification	0.72	0.49–1.04	0.077
Radiation therapy	0.51	0.26–1.03	0.060
Residual tumor	1.42	1.13–1.8	0.003	1.33	1.03–1.71	0.026
MEX3A	2.29	1.61–3.26	0.000	2.26	1.58–3.23	0.000

Notes.

P-value in bold represent significant clinical significance (p < 0.05)